Media OutReach

Media OutReach

Media OutReach

GAC AION Unveils the Aion V: Redefining Electric Mobility with Advanced Technology and Design

SINGAPORE – Media OutReach Newswire – 28 February 2025 – GAC AION, the electric vehicle division of VINCAR Group, is pleased to announce the launch of the Aion V electric SUV. This new model introduces advanced features and a sustainable design, setting new benchmarks in the electric vehicle market. Exterior View of Aion V Product Highlights The AION V offers a WLTP range of 485km per charge, making it the longest-range option in Category A. It features 3C fast charging technology, allowing up to 300 km of range to be recharged in 15 minutes, the fastest charging EV in its category. Designed for comfort, it includes a spacious interior with 180-degree lie-flat front seats and massage seats, a first in its category. Design and Luxury The Aion V electric SUV features a T-Rex Cyber Design with geometric shapes and full LED headlights, available in eight colour options. The interior is designed for comfort and convenience, incorporating soft-touch materials, premium leather seating, and front seats with memory, massage, heating, and ventilation functions. Additional features include a smart multi-function refrigerator, a panoramic glass roof, and a 9-speaker premium sound system with noise-reducing cabin materials to enhance the driving experience. Innovative Technology Equipped with the Snapdragon 8155P processor and AEP 3.0 platform, the Aion V smart car is designed for efficient performance and responsive operation. It includes L2 intelligent driver assistance and intelligent navigation with charging station search capabilities for enhanced safety and convenience. Future models are set to be upgraded to L2+, incorporating automatic parking and highway drive assist. The vehicle also supports voice control, CarPlay, and Android Auto for seamless connectivity. Safety and Performance The Aion V electric SUV is built with a high-strength body, utilising 72% lightweight materials and Magazine Battery 2.0 technology, designed to meet EURO NCAP’s 5-star safety standards. The battery has undergone extensive testing, demonstrating stability under various conditions. Safety features include a centre airbag, extended airbag curtain, blind-spot monitoring, and a 360-degree camera system, providing enhanced driver awareness and occupant protection. Sustainable Impact Aligned with sustainable transportation goals, the Aion V electric SUV operates under a zero-emissions design, reducing pollution and improving energy efficiency. Its 18-in-1 Integrated Power Unit achieves 17.2 kWh/100 km energy consumption, while Silicon Carbide Technology optimises power usage and extends driving range. The Lithium Iron Phosphate (LFP) battery enhances safety, sustainability, and longevity, supporting the brand’s commitment to energy-efficient electric mobility. “Our new Aion V model epitomises GAC AION’s commitment to pushing the boundaries of what electric vehicles can offer. We are not just selling cars; we’re paving the way for a cleaner, more sustainable future where electric mobility is accessible to everyone,” shared Ernest Tan, Deputy CEO, VINCAR Group. Market Availability The Aion V electric SUV will be available for purchase on 26 February 2025, exclusively through the authorised dealer GAC AION and VINCAR Group. It is priced at $174,988, with a launch discount of $6,000, bringing the effective price to $168,988. The price is valid until March 5, 2025, at 12 PM, and includes a COE rebate of $87,000 under the Non-Guaranteed 8 Bids scheme. For more details or to book a test drive, visit the Aion V website. Hashtag: #GACAION https://aionev.com.sg/https://www.facebook.com/aion.sg/https://www.instagram.com/aion.sg/# The issuer is solely responsible for the content of this announcement. About GAC AION GAC AION is dedicated to advancing electric mobility, prioritising accessibility, transparency, and reliability. The company’s mission is to make electric vehicle ownership achievable for all, underpinned by a steadfast commitment to innovation and quality. About VINCAR Group VINCAR Group is a leading multi-brand car dealer and importer in Singapore, focused on innovation and customer experience. They offer in-house financing, leasing, insurance, and after-sales services, prioritising a customer-centric approach. Committed to value and quality, VINCAR Group provides competitive pricing and a diverse vehicle selection, ensuring reliability through their rigorous vetting process.

Media OutReach

Tineco Unveils Two Revolutionary Floor Washers with Super New Arrival Promotion Starting from February 28th

Tineco launches two new floor washers: Floor One S9 Artist and Floor One Switch S7 Stretch Promotion available from February 28th to March 28th, 2025, with attractive gift-with-purchase and more! These innovative floor washers combine cutting-edge technology, energy efficiency, and sleek design for a superior cleaning experience SINGAPORE – Media OutReach Newswire – 28 February 2025 – In response to the common challenges faced by homeowners—such as stubborn odours, tangled hair, and the inconvenience of using multiple cleaning tools—Tineco has unveiled its latest innovations: the Floor One S9 Artist and Floor One Switch S7 Stretch. These next-generation floor washers offer exceptional flexibility, powerful deep-cleaning performance, and an enhanced user experience, designed to meet the needs of today’s modern households. FLOOR ONE S9 ARTIST: ADVANCED 360° CLEANING WITH HYPER STRETCH TECH AND SELF-CLEANING INNOVATION The Floor One S9 Artist offers an advanced solution for modern homes. Featuring the 360° SmoothDrive Technology, it reduces handholding effort by 50%* through flexible left-right movement and a 90° Swivel Design, which adjusts the speed of the left and right wheels in real-time. In addition, the transmission of signals to the AI chip enables intelligent matching, ensuring smooth forward pushing, backward pulling, and effortless steering. Additionally, the Floor One S9 Artist incorporates Hyper Stretch Technology, featuring a slim 12.85 cm flat height, which allows easy access under furniture to effectively remove hidden dust and ensure no corner is left untouched. With exceptional cleaning performance, the Floor One S9 Artist features a Dual-Block Anti-Tangle Design that efficiently handles both pet and human hair without tangling. The MHCBS (Maintain Hygiene Clean Brush System) continuously rinses the brush with fresh water, while a squeegee presses against the roller brush to scrape off dirt and immediately sucks the dirty water into the wastewater tank. Additionally, the Flashdry Self-Cleaning System enhances cleaning efficiency by using 85°C hot air to heat fresh water, dissolving stains from the pipe to the brush roller for a deeper, more thorough self-cleaning result. Upgrades were also made to enhance user experience, such as the Backtrack Water Erasure function that eliminates water streaks, and the Repositioned Clean Water Tank that enhances cleaning efficiency with reduced weight for effortless operation. The optional Electrolyzed Water feature delivers a superior cleaning experience, making the Floor One S9 Artist a versatile and user-friendly floor care solution. FLOOR ONE SWITCH S7 STRETCH: THE 5-IN-1 CLEANING REVOLUTION FOR EFFORTLESS FLOOR CARE The Floor One Switch S7 Stretch is a 5-in-1 cleaning tool, combining floor washing, vacuuming, crevice cleaning, soft surface care, and high-reach dusting into one compact device. Designed to replace traditional vacuums, it effortlessly handles wet and dry messes, including oily stains and hard-to-clean debris. The Floor One Switch S7 Stretch revolutionizes floor cleaning with its advanced washing capabilities. With 22KPa of suction power, it effortlessly lifts dirt, debris, and hair, ensuring a deep and thorough clean every time. Like the Floor One S9 Artist, it features the MHCBS, which rinses the brush with fresh water 450 times per minute to guarantee spotless floors. The 180° lay-flat design and HyperStretch Technology allow it to clean under furniture and reach tight spaces as low as 13cm. Its Dual-Block Anti-Tangle Design prevents hair tangles, while dual-sided edge cleaning ensures no corner is left untouched. The FlashDry Self-Cleaning System utilizes fresh water heated to 85°C, combined with hot air, to dissolve stains and dry the brush in just 5 minutes, keeping it fresh and odour-free. The Floor One Switch S7 Stretch also excels as a powerful vacuum cleaner. With its 5-stage filtration system which captures 99.97% of dust and debris as small as 0.3μm. Meanwhile, the ZeroTangle Brush effortlessly picks up hair without wrapping, and an LED headlight illuminates hard-to-reach areas, making cleaning under furniture effortless. The vacuum mode offers up to 70 minutes of runtime, powered by upgraded pouch cells that triple battery lifespan. Images available in the media kit here. AVAILABILITY & LAUNCH PROMOTIONS Device Availability Launch Promotions T&Cs apply, while stocks last Floor One S9 Artist Available now on Shopee, Lazada, TikTok Shop and Mass Retailers Free Tineco iCarpet Spot Cleaner (worth S$379) + 6 bottles of cleaning solution Floor One Switch S7 Stretch Available now on Shopee, Lazada, TikTok Shop and Mass Retailers Free Tineco iCarpet Spot Cleaner (worth S$379) + 6 bottles of cleaning solution TINECO ROADSHOW AT PAVILION DAMANSARA HEIGHTS, KUALA LUMPUR Happening on March 5th, Tineco will celebrate the launch of these two floor washers with a roadshow at Pavilion Damansara Heights (Centre Court), where visitors can try out the superior cleaning experience for themselves, score special deals and win prizes. -END- Hashtag: #Tineco The issuer is solely responsible for the content of this announcement. About Tineco Founded in 1998, Tineco is a high-tech company and a wholly-owned subsidiary of ECOVACS Group (SHA: 603486). Dedicated to innovation, Tineco has consistently delivered smart home cleaning solutions that redefine convenience and efficiency. With the launch of the Floor One S9 Artist and Floor One Switch S7 Stretch, Tineco continues to lead the way in creating products that make everyday life easier and more enjoyable.

Media OutReach

Gorilla Technology Featured in Nasdaq Amplify Issuer Spotlight: Showcasing Global Expansion and AI-Driven Innovation

London, United Kingdom – Newsfile Corp. – February 27, 2025 – Gorilla Technology Group Inc. (NASDAQ: GRRR) (“Gorilla” or the “Company”) today announced that its Chief Executive Officer, Jay Chandan, was recently featured in the Nasdaq Amplify Issuer Spotlight interview series at the Nasdaq MarketSite in Times Square. Watch the full interview with Gorilla CEO Jay Chandan on Gorilla’s investor relations website here. To view an enhanced version of this graphic, please visit: https://images.newsfilecorp.com/files/10783/242631_066cc868f469bbf3_001full.jpg During the interview, Chandan shared insights into Gorilla Technology’s role in building smart cities, enhancing security, and fostering sustainability through AI-powered solutions. He emphasized the Company’s unique consultative approach, working closely with governments and organizations to deliver tailored AI-based cybersecurity and data-driven technologies that address real-world challenges. “We built a platform which is unbeatable,” said Chandan. “We’re not just selling a product-we’re providing a consultative approach that ensures long-term impact. Our success stems from our ability to listen to our customers, understand their pain points, and deliver AI-driven solutions tailored to their needs.” The Nasdaq Amplify Issuer Spotlight series highlights innovative small-cap companies navigating dynamic industry landscapes and emerging as leaders in their respective fields. Watch the full interview with Gorilla CEO Jay Chandan on Gorilla’s investor relations website here. About Gorilla Technology Group Inc. Headquartered in London U.K., Gorilla is a global solution provider in Security Intelligence, Network Intelligence, Business Intelligence and IoT technology. We provide a wide range of solutions, including, Smart City, Network, Video, Security Convergence and IoT, across select verticals of Government & Public Services, Manufacturing, Telecom, Retail, Transportation & Logistics, Healthcare and Education, by using AI and Deep Learning Technologies. Our expertise lies in revolutionizing urban operations, bolstering security and enhancing resilience. We deliver pioneering products that harness the power of AI in intelligent video surveillance, facial recognition, license plate recognition, edge computing, post-event analytics and advanced cybersecurity technologies. By integrating these AI-driven technologies, we empower Smart Cities to enhance efficiency, safety and cybersecurity measures, ultimately improving the quality of life for residents. For more information, please visit our website: Gorilla-Technology.com. Forward-Looking Statements This press release contains “forward-looking statements” within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. Gorilla’s actual results may differ from its expectations, estimates and projections and consequently, you should not rely on these forward-looking statements as predictions of future events. Words such as “expect,” “estimate,” “project,” “budget,” “forecast,” “anticipate,” “intend,” “plan,” “may,” “will,” “could,” “should,” “believes,” “predicts,” “potential,” “might” and “continues,” and similar expressions are intended to identify such forward-looking statements. These forward-looking statements include, without limitation, statements regarding our beliefs about our ability to execute definitive agreements related to this smart education project, attract the attention of customers and win additional projects, along with those other risks described under the heading “Risk Factors” in the Form 20-F Gorilla filed with the Securities and Exchange Commission (the “SEC”) on May 15, 2024 and those that are included in any of Gorilla’s future filings with the SEC. These forward-looking statements involve significant risks and uncertainties that could cause actual results to differ materially from expected results. Most of these factors are outside of the control of Gorilla and are difficult to predict. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those indicated or anticipated by such forward-looking statements. Readers are cautioned not to place undue reliance upon any forward-looking statements, which speak only as of the date made. Gorilla undertakes no obligation to update forward-looking statements to reflect events or circumstances after the date they were made except as required by law or applicable regulation. Contact: Dave Gentry, CEO RedChip Companies, Inc. 1-407-644-4256 [email protected] The issuer is solely responsible for the content of this announcement. About Gorilla Technology Group Inc.

Media OutReach

Captiva Verde and Matnaggewinu Development Corp (MDC) Welcome Brandon Schilling to Aviation and Military Advisory Board

Vancouver, British Columbia – Newsfile Corp. – February 27, 2025 – Captiva Verde (CSE: PWR) (OTC Pink: CPIVF) and Matnaggewinu Development Corp (MDC), a Mi’kmaq-owned joint venture partner of Captiva Verde, are pleased to announce the appointment of Brandon Schilling to the Aviation and Military Advisory Board. Brandon brings an impressive background in aerospace, defense, space systems, Foreign Military Sales (FMS), and Maintenance, Repair, and Overhaul (MRO) industries, further strengthening MDC’s efforts to expand into these rapidly growing markets. Captiva Verde is a publicly traded company listed on the Canadian Securities Exchange (CSE) under the symbol PWR and the US OTC Market under the symbol CPIVF Brandon Schilling’s Experience and Expertise Brandon Schilling is a career professional with extensive experience across the aerospace, defense, space systems, FMS, and MRO industries. Throughout his career, he has demonstrated exceptional leadership and expertise in business development, aviation sales, and strategic market growth. He has led and overseen the development and growth of profitable new aircraft sales, managing deal sizes ranging from $3.5 million to $700 million. Brandon has cultivated key relationships with in-country sales agents, embassy personnel, and high-ranking foreign military commanders and generals. His efforts ensured business growth by aligning business development activities with organizational strategies. While at MD Helicopters, he identified and developed new commercial and military customers for MD products, including 500, 600, and 902 class helicopters. He developed market intelligence to focus business development efforts and created multi-year sales forecasts to meet annual operating plans. In the space sector, Brandon worked with leading organizations such as NASA, NSPO, SpaceX, JPL, USAF, United Launch Alliance, and Astrobotics. He negotiated and contracted lunar payloads for NASA’s CLPS program aboard the Masten lunar lander. He conducted research and analysis on U.S. and international civil space markets, industry trends, policy developments, and competitive landscapes, supporting business development processes and strategic decision-making. Brandon has also excelled in managing contracts and sales across global aviation and aerospace sectors. At Able Aerospace, he maintained and managed over 120 worldwide aviation contracts, including with major rotor wing OEMs and APAC airlines such as Bell, Leonardo Agusta Westland, Asiana Airlines, and Korean Airlines. He successfully grew a client’s business by 440% from 2019 to 2020. His expertise includes responding to customer RFPs/RFQs, negotiating long-term agreements (LTAs), and leading multi-disciplinary teams for business capture and proposal efforts. MDC Aviation Mission Statement At MDC Aviation, our mission is to empower Mi’kma’ki’s economic resurgence by leveraging our expertise in aviation and military equipment advisory and sales. We are dedicated to serving as a dynamic platform that champions Indigenous innovation and leadership in the aerospace and defense sectors. Through strategic procurement and targeted set-aside programs, we aim to drive sustainable growth, foster robust partnerships, and ensure our community competes on a global scale while honoring our rich cultural heritage. Our Story Founded by Nowlen Augustine, a proud Mi’kmaq and former US Marine, driven by a commitment to excellence and service, MDC Aviation was born from a vision of economic revitalization in Mi’kma’ki. Rooted in the enduring spirit and traditions of our people, MDC Aviation is more than a business-it is a transformative platform that bridges Indigenous heritage with advanced aviation and military capabilities. Drawing on Nowlen’s invaluable military experience and leadership, we offer cutting-edge advisory services and access to state-of-the-art military and aviation equipment. By leveraging strategic procurement and set-aside initiatives, we pave the way for enhanced Indigenous participation and leadership in a competitive global landscape. At MDC Aviation, our mission is to empower our communities, foster sustainable growth, and honor our proud legacy while driving progress in the aerospace and defense sectors. A Growing Market and Unprecedented Opportunity The aerospace, defense, and space system markets present significant growth potential for Indigenous-owned businesses. These industries are driven by increased government spending, technological advancements, and the expanding role of private sector companies. The Canadian government has recognized the essential role that Indigenous businesses play in driving economic growth, innovation, and community empowerment. By incorporating Indigenous businesses into its procurement processes, the Canadian government is creating an ideal environment for companies like MDC to thrive in the following key markets: Aerospace Industry: Global Market Size: The civil aviation market is projected to reach $1.2 trillion by 2027, growing at a compound annual growth rate (CAGR) of 4.5%. MRO Services: Maintenance, Repair, and Overhaul (MRO) services for commercial aviation alone are expected to exceed $90 billion annually by 2027, driven by the demand for fleet expansion and maintenance. Defense Industry: Global Defense Spending: The global defense market is valued at over $2 trillion, with U.S. defense spending surpassing $800 billion annually. Canadian Defense Budget: Canada is significantly increasing its defense spending, with $35 billion earmarked for modernizing military platforms, creating procurement opportunities for companies like MDC. Foreign Military Sales (FMS): The U.S. FMS program consistently exceeds $50 billion annually, providing defense systems to allied nations and opening new markets for Indigenous businesses. Space Systems: The Global Space Economy is projected to grow from $500 billion in 2024 to $1 trillion by 2040, driven by investments in satellite technology, space exploration, and defense applications. The U.S. Space Force and the Canadian Space Agency (CSA) are key players in developing military satellite systems and space-based surveillance. Positioning for Success Matnaggewinu Development Corp’s entry into aerospace, defense, and space systems markets aligns with this growing demand and government initiatives to include more Indigenous businesses in procurement processes. Brandon Schilling’s expertise will help position MDC as a key player in these sectors, leveraging Indigenous procurement programs and set-aside opportunities in Canada and the U.S. Captiva Verde and MDC remain committed to building partnerships and exploring innovative solutions in these high-growth industries while fostering economic empowerment for Mi’kmaq communities. About Matnaggewinu Development Corp (MDC) Matnaggewinu Development Corp is a Mi’kmaq-owned joint venture focused on innovation and growth in the aerospace, defense, and space systems sectors. With a mission to create sustainable business opportunities and promote Indigenous leadership in high-tech industries, MDC leverages strategic partnerships and government procurement programs to

Media OutReach

Ne Zha 2 Dominates Hong Kong Box Office for Four Straight Days, Crowned 2025’s Top Film

SHANGHAI, CHINA – Media OutReach Newswire – 27 February 2025 – Chinese animated blockbuster Ne Zha 2 has taken Hong Kong by storm, topping the city’s box office charts for four consecutive days since its release. As of now, its cumulative earnings in Hong Kong have surpassed $2.07 million, securing its position as 2025’s highest-grossing film in the region. The premiere of the Chinese animated blockbuster “Ne Zha 2” was held in Hong Kong on February 18. The sequel to the 2019 hit “Ne Zha” premiered in Hong Kong on February 18 and hit the theaters on February 22, drawing enthusiastic crowds and critical acclaim. The film reimagines the mythical tale of Ne Zha—a divine warrior from Chinese folklore—with modern storytelling and cutting-edge animation, captivating audiences across the Chinese mainland since its Lunar New Year debut. The Hong Kong premiere at Causeway Bay drew a star-studded crowd, including representatives from its Hong Kong and Macau distribution teams, local cultural figures, and residents. Industry professionals praised the film’s technical brilliance and narrative depth, with many cinemas, such as Kowloon Tong’s Festival Grand Cinema, scheduling near hourly screenings to meet demand. The billboards in Hong Kong cinemas promoting the release of “Ne Zha 2” on February 22.) Two Hong Kong moviegoers shared their excitement after attending early screenings. One resident remarked, “I don’t usually watch adult-oriented animated films, but this one is definitely worth watching. Chinese animation can now rival, or even surpass, foreign productions.” Another added, “Chinese animation keeps improving. Compared to films six years ago, the artwork is more beautiful, the visuals more vibrant, and the storytelling completely unexpected.” LO Shuk-pui, Director of the Hong Kong SAR Government’s Culture, Sports, and Tourism Bureau, highlighted the film’s collaborative effort, stating, “The script is exceptionally well-written, with sharp dialogue and rich character development. I heard 138 companies worked on this project over five years—the dedication and technical excellence are evident.” WONG Bak-ming, Chairman of Hong Kong’s Oriental Film Company, emphasized its cultural significance, noting that Ne Zha series has successfully brought traditional Chinese stories to the global stage. It proves Chinese animation can achieve world-class results, and they’re proud to contribute to this milestone. Globally, Ne Zha 2 has grossed over $1.698 billion as of February 18, surpassing “Inside Out 2” to become the highest-grossing animated film in history and entering the top eight of the all-time global box office chart. Due to its sustained popularity, the film’s screening period in Chinese mainland has been extended to March 30. From its mythological roots to its record-breaking success, Ne Zha 2 continues to redefine the possibilities of Chinese animation, bridging cultural heritage with global appeal. Hashtag: #ShanghaiEye The issuer is solely responsible for the content of this announcement.

Media OutReach

Medicus Pharma Ltd Announces Submission of Phase 2 Clinical Design (SKNJCT-004) to UAE Department of Health (DOH) to Non-Invasively Treat Basal Cell Carcinoma of the Skin (BCC)

The Clinical Study is Expected to Randomize 36 Participants in Cleveland Clinic Abu Dhabi (CCAD) and Three Other Clinical Sites in UAE Philadelphia, Pennsylvania – Newsfile Corp. – February 27, 2025 – Medicus Pharma Ltd. (NASDAQ: MDCX) (“Medicus” or the “Company”) is pleased to announce that it has submitted a clinical design (SKNJCT-004) to UAE DOH to non-invasively treat BCC of the skin. The study is expected to randomize thirty-six (36) patients in four sites in UAE, which are Cleveland Clinic Abu Dhabi (CCAD), Sheikh Shakbout Medical City (SSMC), Burjeel Medical City (BMC), and American Hospital of Dubai (AHD). Insights Research Organization and Solutions (IROS), a UAE-based contract research organization, is coordinating the clinical study for the Company. IROS is a M42 portfolio company. Clinical Trial Design (SKNJCT-004) The clinical study, SKNJCT-004, is designed to be a randomized, double-blind, placebo-controlled (P-MNA), multi-center study enrolling up to 36 subjects presenting with BCC of the skin. The study will evaluate the efficacy of two dose levels of D-MNA compared to a placebo control. The participants will be randomized 1:1:1 to one of three groups: a placebo-controlled group receiving P-MNA, a low-dose group receiving 100μg of D-MNA, and a high-dose group receiving 200μg of D-MNA. The high-dose, 200μg D-MNA, proposed in the study is the maximum dose that was used in the Company’s Phase 1 safety and tolerability study (SKNJCT-001) completed in March 2021. SKNJCT-001 met its primary objective of safety and tolerability. The investigational product, D-MNA, was well tolerated across all dose levels in all 13 participants enrolled in the study, with no dose-limiting toxicities (DLTs), or serious adverse events (SAEs). Furthermore, there were no systemic effects or clinically significant abnormal findings in laboratory parameters, vital signs, ECGs, and physical examinations. The study also describes the efficacy of the investigational product, D-MNA, with 6 participants experiencing complete responses. The complete response is defined as the disappearance of BCC histologically in the final excision at the end of study visit. The participants profile demonstrating complete responses was diverse, and all participants (6/6) had nodular subtype of BCC. The Company also has SKNJCT-003 Phase 2 clinical study currently underway in 9 clinical sites in the United States, which is expected to randomize 60 patients. The patient recruitment in this study, which began in August 2024, has now randomized more than 50% of the 60 patients expected to be enrolled in the study. The Company is on track to complete an interim data analysis of SKNJCT-003 before the end of Q1 2025 and to submit its findings to the United States Food and Drug Administration (FDA) as part of a package seeking a Type C meeting with the FDA in Q2 2025. The purpose of the Type C meeting is to formally discuss the product development and gain further alignment on the clinical pathway. The Company’s aim is to gain FDA’s consent to fast-track the clinical development program. “We are making substantial progress in expanding the clinical development program of our novel non-invasive treatment to cure the most common cancer in the world, beyond the shores of United States, stated Dr. Raza Bokhari, Executive Chairman & CEO. “UAE is rapidly emerging as a significant hub for Pharmaceutical R&D, driven by strategic investments, public-private partnerships and a commitment to innovation. A clinical study in the middle east will help us gather useful efficacy and safety data. It will also help us strengthen our clinical development program, as we aspire to bring to market not only the first-in-class, but also the best-in-class, novel non-invasive treatment regimen for BCC”. For further information contact: Carolyn Bonner, President (610) 636-0184 [email protected] Jeremy Feffer LifeSci Advisors (212) 915-2568 [email protected] About Medicus Pharma Ltd: Medicus Pharma Ltd. (Nasdaq: MDCX) is a biotech/life sciences company focused on accelerating the clinical development programs of novel and disruptive therapeutics assets. SkinJect Inc. a wholly owned subsidiary of Medicus Pharma Ltd, is a development stage, life sciences company focused on commercializing novel, non-invasive treatment for basal cell skin cancer using patented dissolvable microneedle patch to deliver chemotherapeutic agent to eradicate tumors cells. The Company has completed a phase 1 safety & tolerability study (SKNJCT-001) in March of 2021, which met its primary objective of safety and tolerability; the study also describes the efficacy of the investigational product D-MNA, with six (6) participants experiencing complete response on histological examination of the resected lesion. The Company submitted a Phase 2 IND clinical protocol to the FDA in January 2024 for a randomized, controlled, double-blind, multicenter clinical study (SKNJCT-003) that is expected to randomize up to 60 patients. The study is designed to evaluate the efficacy of two dose of two dose levels (100 and 200 ug) of D-MNA compared to placebo (P-MNA) in subjects with nodular BCC. Patient recruitment is currently underway in nine sites across the United States. Cautionary Notice on Forward-Looking Statements Certain information in this news release constitutes “forward-looking information” under applicable securities laws. “Forward-looking information” is defined as disclosure regarding possible events, conditions or financial performance that is based on assumptions about future economic conditions and courses of action and includes, without limitation, statements regarding the Company’s plans and expectations concerning, and future outcomes relating to, the submission and advancement of the phase 2 clinical protocol, the randomization of patients and size of the study, the Company’s intention to complete and submit an interim data analysis to the FDA and to request a Type C meeting and the timing thereof, the Company’s aim to fast fast-track the clinical development program and convert the SKNJCT-003 exploratory clinical trial into a pivotal clinical trial, and approval from the FDA and the timing thereof. Forward-looking statements are often but not always, identified by the use of such terms as “may”, “on track”, “aim”, “might”, “will”, “will likely result”, “would”, “should”, “estimate”, “plan”, “project”, “forecast”, “intend”, “expect”, “anticipate”, “believe”, “seek”, “continue”, “target” or the negative and/or inverse of such terms or other similar expressions. These statements involve known and unknown risks, uncertainties and other factors, which may

Media OutReach

First Phosphate Updates on Corporate Developments, Management Appointments and Insider Stock Purchases

Saguenay, Quebec – Newsfile Corp. – February 27, 2025 – First Phosphate Corp. (CSE: PHOS) (OTCQB: FRSPF) (FSE: KD0) (“First Phosphate” or the “Company“) is pleased to announce the following corporate updates. Bégin-Lamarche Phosphate Mine The Company recently concluded its National Instrument 43-101 (“NI-43-101”) compliant mineral resource estimate (September 2024) and its NI 43-101 compliant Preliminary Economic Assessment (December 2024) for its Bégin-Lamarche property. The Company is in the process of completing its internal pre-feasibility analysis and is readying to launch its formal feasibility study. Buildout capex for the mine is estimated at US $459 million. Annual mine revenues over 23 years are expected to peak at US $362 million at a 37.1% pre-tax IRR. In December 2024, the Company announced definitive long-term agreements with creditworthy offtake partners that are not impacted by the current North American trade-tariff situation. The Company also continues to work towards project financial participation in the Bégin-Lamarche mining project by its indigenous partner, Pekuakamiulnuatsh First Nation. Phosphoric Acid Facility In December 2024, the Company concluded licensing and engineering agreements for a 190,000 tonne per annum phosphoric acid facility. The internal pre-feasibility and capex study for the facility has now completed by engineering firm Ballestra S.pA. (though not NI 43-101 compliant). Buildout capex for the facility is estimated at US $175 million. Revenues from the facility at today’s prices could total $284 million per annum using directly produced apatite concentrate from the Company’s future Bégin-Lamarche phosphate mine. Definitive offtake in place for this facility is not impacted by the current North American trade-tariff situation. First Saguenay Iron Phosphate Plant In September, 2024, La Baie, Quebec was chosen as the site for the Company’s First Saguenay iron phosphate facility. The feasibility study for the facility has now been fully completed by Ultion Technologies Inc. (though not NI 43-101 compliant). Pending financing, First Saguenay is expected to start small-scale production of iron phosphate pre-cursor material in 2026 ramping up to 11,882 tonnes per annum by 2028 with yearly revenues projected at US $53 million. Funding costs for the facility are estimated at US $76 million. Funding discussions for the facility are ongoing and proceeding as expected. The Company is also waiting for clarity on the impact of the North American trade-tariff situation before assessing its final deployment timelines and rollout plans. Building owner Logistique Proco Inc. has pledged maximum flexibility in terms of lease uptake. The Company has also located various secondary plant development locations in the United States should the North American trade-tariff situation require production facilities in multiple countries. The Company is currently negotiating definitive supply agreements with major purchasers of LFP CAM materials in various segments of the LFP battery industry. In November 2024, the Company signed a collaboration agreement with GKN Hoeganaes, a division of GKN Powder Metallurgy and one of the largest iron powder producers globally. GKN will be able to supply the Company with up to 400,000 tonnes of iron powder required to be able to eventually scale iron phosphate pre-cursor using large economies of scale. GKN Hoeganaes was also successful in integrating the Company’s magnetite (a secondary recovery from its Bégin-Lamarche property) into the GKN proprietary Ancorsteel melting process. This innovative process has led to the development of a high-purity iron powder, which can serve as an input for iron phosphate pre-cursor production. Given, this development, the Company should be in a position to create iron phosphate precursor from both the phosphate and the iron material emanating from its Bégin-Lamarche property to achieve full backwards integration with the mine source. The commencement of the industrial operations proposed by the Company, including the Bégin-Lamarche phosphate mine, phosphoric acid facility and the First Saguenay iron phosphate facility, are subject to a number of conditions, including permitting and financing which the Company continues to work towards diligently. Management Appointments Armand MacKenzie has been promoted to the post of President of the Company and David Dufour to the position of Senior Vice-President. “Armand and David have proven their abilities to assume team leadership. Armand will lead discussions with our indigenous partner and indigenous financial institutions to ensure we meet our objective of having deep Indigenous financial participation in the Company. David will drive operations and community relations as we begin to enter into the next stages of planning of our feasibility study,” said John Passalacqua, CEO of First Phosphate. Insider Stock Purchases Company Chairman, Laurence W. Zeifman, has acquired, through a corporation controlled by him, a total of 40,000 common shares of the Company for $7,475 in the open market since January 1, 2025. Mr. Zeifman has made open market purchases of 359,500 shares for $74,390 since the Company has been publicly listed in February 2023. Company Independent Director, Peter Nicholson, has acquired, through a corporation controlled by him, a total of 197,500 common shares of the Company for $58,945 in the open market since January 1, 2025. Mr. Nicholson has made open market purchases of 532,000 shares for $146,415 since joining as director in September 2024. CEO, John Passalacqua, has acquired, through an entity controlled by him, a total of 811,000 common shares of the Company for $262,424.45 in the open market since January 1, 2025. Mr. Passalacqua has made open market purchases of 1,861,500 shares for $507,324 since the Company has been publicly listed in February 2023. Company management continues to receive 80% of its compensation in the form of RSUs while the Company board of directors receives 100% of its compensation in the form of RSUs. All is done with the intent of keeping capital resources focused on the development of the Company and to have management and board more deeply involved in the ownership structure of the Company. The Company has approved the grant of 2,658,580 restricted share units of the Company (“RSUs”) to eligible directors, management and staff of the Company as part of compensation expenses for the 6 month period commencing March 1, 2025. The RSUs vest on August 31, 2025 and shares issued under these RSUs will

Media OutReach

Budget to maintain Hong Kong’s competitiveness amid fiscal consolidation

HONG KONG SAR – Media OutReach Newswire – 27 February 2025 – Hong Kong SAR’s Financial Secretary Paul Chan delivered his 2025-26 Budget yesterday (February 26), with clear path and initiatives to rein in the deficit, while accelerating the city’s development and maintaining its competitive edge of a low and simple tax regime. “The key is managing expenditure growth, making good use of the Government’s fiscal resources, and identifying new revenue resources,” Mr Chan said. Hong Kong SAR’s Financial Secretary, Paul Chan (second left), at a press conference on the 2025-26 Budget He forecast a consolidated deficit of $87.2 billion for 2024/25 with the Operating Account returning to surplus within two years. The deficit, Mr Chan said, was largely due to the impact of counter-cyclical measures launched in response to the COVID-19 pandemic as well as challenges such as the geopolitical landscape and related disruptions to trade, supply chain, cash flow and sentiment in the investment market. Under a proposed “reinforced version” of the fiscal consolidation programme, Mr Chan announced a range of measures, including a cumulative reduction of 7% in government expenditure by 2027-28, compared to the level in 2024-25. The Government has also put forward that the executive authorities, the legislature, the judiciary and members of the District Councils take a pay freeze for 2025-26. That includes, among others, the Chief Executive and all politically appointed officials, and all civil servants. The civil service establishment will be reduced by 2% each in 2026-27 and 2027-28, with about 10,000 posts expected to be deleted within the next two years. “The Government has all along endeavoured to deliver more efficient public services to citizens through leveraging technology, streamlining processes and driving the digital transformation of public services,” Mr Chan said. The Budget proposes a reinforced version of fiscal consolidation programme to restore fiscal balance in the Operating Account within the current term of Government Meanwhile, the conditions of the two public transport fare subsidy schemes will be adjusted, with expected saving of $6.2 billion in the next five years. Alongside controls on government expenditure, the Financial Secretary proposed a raft of measures to boost revenue, notably by adjusting some government fees and charges under the “user pays” and “affordable users pay” principle. These include, for example, reviewing government fees and charges for road users in relation to some tunnel tolls, trunk roads, licences and parking charges, and increasing the rate of air passenger departure tax from $120 to $200 per passenger starting from October 2025. The Financial Secretary noted that issuing bonds to support infrastructure development is a common practice worldwide. To take forward major infrastructure projects, particularly the Northern Metropolis development, Mr Chan said “Hong Kong has the prerequisite and capability to suitably increase bond issuance, thereby effectively utilising market resources.” “With the increase in capital works expenditure, I will expand the scale of bond issuance accordingly. It is expected that during the five-year period from 2025-26 to 2029-30, a total of about $150 billion to $195 billion worth of bonds will be issued under the Government Sustainable Bond Programme and the Infrastructure Bond Programme every year.” He remarked that bonds will not be issued to fund government recurrent expenditure; instead, they will be used to invest in infrastructure only. The ratio of Hong Kong SAR Government debt to GDP will stay at 12 to 16.5 per cent, which is a prudent and manageable level, and is much lower than most of the advanced economies, Mr Chan emphasised. Hashtag: #hongkong #brandhongkong #asiasworldcity #budget https://www.brandhk.gov.hk/https://www.linkedin.com/company/brand-hong-kong/https://x.com/Brand_HK/https://www.facebook.com/brandhk.isdhttps://www.instagram.com/brandhongkong The issuer is solely responsible for the content of this announcement.

Media OutReach

Samitivej International Children’s Hospital Expands, Advancing Pediatric Healthcare in Asia-Pacific

A 2 Billion THB Investment in Pediatric Excellence and Smart Hospital Innovation BANGKOK, THAILAND – Media OutReach Newswire – 27 February 2025 – Samitivej Hospital, a leader in pediatric care, unveils its newly expanded standalone Samitivej International Children’s Hospital at Samitivej Srinakarin Hospital. Backed by a 2 billion THB investment, the expansion strengthens Samitivej’s commitment to becoming Asia-Pacific’s Leading Pediatric Referral Hub, providing specialized care, innovative treatments, and seamless medical coordination. Samitivej International Children’s Hospital Expands, Advancing Pediatric Healthcare in Asia-Pacific The upgraded facility serves patients from Thailand and beyond, earning a strong reputation in Vietnam, Laos, Cambodia, Indonesia, Brunei, Saudi Arabia, the UAE, Kuwait, Oman, and Qatar, reinforcing its global healthcare role. Revolutionizing Pediatric Care with Advanced Treatments Samitivej International Children’s Hospital redefines pediatric excellence, offering cutting-edge treatments for complex and rare conditions: Open-Heart Surgery to Minimally Invasive Catheterization – Complete heart care from birth, ensuring advanced treatment and faster recovery. Haploidentical Bone Marrow Transplant (BMT) to CAR-T Cell Therapy – Advanced treatments for blood disorders and cancer. Comprehensive Pediatric and Newborn Surgery – Expertise in performing procedures from head to toe, led by specialized doctors. Epilepsy Treatment with Medication to Vagus Nerve Stimulation (VNS) Implants – Solutions for drug-resistant epilepsy. Advancing Pediatric Excellence with Cutting-Edge Facilities The new eight-floor hospital features 111 beds, including 12 for critically ill children and 8 neonatal intensive care beds. It integrates Smart Hospital technology for efficiency and patient-centered care. Key features include: Hybrid Operating Room: Precision-driven newborn and pediatric surgical procedures using biplane imaging technology. World-Class Pediatric Specialties: Multidisciplinary teams treating complex and rare conditions. Advanced Neonatal & Pediatric Intensive Care: Specialized care for premature infants under 500 grams. Cutting-Edge Rehabilitation Center: Robotic-assisted gait training, Hybrid Assistive Limb (HAL) therapy, and Redcord NEURAC systems. Comprehensive International Patient Services: Pre-arrival teleconsultations, aeromedical transport, multilingual care teams, follow-up appointments, and medical evacuation and repatriation. Global Partnerships & Medical Expertise Samitivej collaborates with Doernbecher Children’s Hospital (OHSU, USA) to enhance care for critically ill children, newborns, and trauma patients. A partnership with Takatsuki General Hospital (Japan) ensures specialized neonatal and allergy treatments, providing access to the latest pediatric advancements. Pioneering Smart Hospital Innovations Samitivej leads in digital healthcare, integrating technology to enhance efficiency and care: Well Kidz App: Manages medical records, appointments, and remote consultations. Smart ER & Smart Ambulance Services: Real-time monitoring ensures rapid emergency response. Smart OPD & Smart IPD: AI-powered cost estimation, queue tracking, and seamless patient-medical team communication. D-Discharge System: Streamlined hospital discharge for greater convenience. Exceptional Pediatric Outcomes & Achievements Samitivej delivers outstanding results: 7,000+ critical pediatric cases treated annually 1,000+ newborn and pediatric surgeries performed, including minimally invasive procedures 92% one-year survival rate for bone marrow transplants, surpassing global benchmarks 400+ newborns with heart conditions successfully treated through surgical correction Specialized care provided for premature infants with birth weights below 500 grams 98% trust rating from families A Commitment to a Healthier Future for Every Child Dr. Surangkana Techapaitoon, Deputy CEO of Samitivej and BNH Hospitals and Director of Samitivej International Children’s Hospital, stated: “We want to see a healthier future for every child by integrating innovation, world-class expertise, and compassionate care. This facility strengthens our role as a leading pediatric referral hub, expanding access to specialized treatment and ensuring children everywhere receive the best care from infancy through adolescence.” For more details, please visit: https://smtvj.com/3F5dPKC Hashtag: #SamitivejInternationalChildrensHospital The issuer is solely responsible for the content of this announcement. About Samitivej Hospital Samitivej is a JCI-accredited hospital group, offering world-class care since 1979. With seven hospitals, it is a leading provider of healthcare in Thailand and Southeast Asia, serving both locals and expatriates.

Media OutReach

Cyberport and International Organisations Co-host “AI Safety, Trust, and Responsibility” Forum

WDTA APAC Institute Inaugurated to Lead AI Governance and Standards Development HONG KONG SAR – Media OutReach Newswire – 27 February 2025 – Cyberport, the World Digital Technology Academy (WDTA) and the International Academicians Science & Technology Innovation Centre (IASTIC) co-organised the “AI Safety, Trust, and Responsibility (AI STR)” Forum. This event served as the Hong Kong session of the recently concluded AI Action Summit 2025 in Paris, France. The forum convened leading international and local academicians, scholars, industry leaders, and experts to share insights on the risks and challenges in AI development and application, and to discuss strategies for balancing innovation with security governance. Prof Sun Dong, Secretary for Innovation, Technology and Industry; Prof Yale Li, Executive Chairman of WDTA; Prof C.C. Chan, Founder of IASTIC, joined Simon Chan, Chairman of Cyberport, and Dr Rocky Cheng, CEO of Cyberport, in delivering keynote addresses and sharing their perspectives on the future of AI. Cyberport, the World Digital Technology Academy (WDTA) and the International Academicians Science & Technology Innovation Centre (IASTIC) co-organise the “AI Safety, Trust, and Responsibility (AI STR)” Forum. The forum convened international and local experts to discuss the strategies for balancing innovation with security governance. Prof Sun Dong, Secretary for Innovation, Technology and Industry, remarked, “To provide the most conducive environment for AI development, Cyberport, being Hong Kong’s digital tech hub, established the AI Supercomputing Centre last year, which will provide high-performance computing power of 3,000 petaFLOPS to support impactful R&D projects on AI. As announced yesterday by the Financial Secretary in the 2025-26 Budget, to establish the Hong Kong AI R&D Institute. A dedicated, public mission-driven undertaking, the institute will spearhead AI development and industry application in Hong Kong, promote cross-sectoral collaboration, and add another exciting chapter in our AI history book. We are mindful of the safety, responsibility and trust issues that beset the AI explorers and users. We could only harness the full power and potentials of AI by addressing these contentious issues proactively.” Simon Chan, Chairman of Cyberport, expressed, “We are delighted to bring together prominent industry experts and leaders from around the world at Cyberport to explore the establishment of a trustworthy and responsible AI ecosystem. This will ensure the controllable, balanced, and sustainable development of this transformative technology. As Hong Kong’s digital tech hub and AI accelerator, Cyberport has achieved significant milestones in building a thriving AI ecosystem over the past year. These include Cyberport’s AI Supercomputing Centre, currently the largest in Hong Kong, and Cyberport’s AI Lab, which unites local AI ecosystem partners and talents to facilitate R&D and collaboration. We look forward to continuing our collaboration across sectors to strengthen Hong Kong’s AI ecosystem and promote AI for good.” During the forum, WDTA announced the establishment of the “WDTA Asia-Pacific Institute (preparatory)” (The Institute) at Cyberport, marked by an official plaque unveiling ceremony. The Institute will spearhead the development of regional AI safety standards and related initiatives, promote innovation in digital technologies, cultivate scientific and industrial talent, and foster global collaboration in the digital era. Prof. Yale Li, Executive Chairman of WDTA, addresses the forum, highlighting WDTA’s recent accomplishments and emphasising the importance of a human-centric and safety-based approach to AI. He outlined three core initiatives: First, to build a “safety-native” technological framework by embedding security throughout the entire AI lifecycle and promoting algorithm transparency and data provenance certification. Second, to establish a “human-oriented” value system that ensures technology addresses social needs, such as equitable healthcare and SME transformation. Finally, WDTA is committed to “responsible innovation” globally, with its AI committee addressing challenges like deepfakes and data misuse within the United Nations Sustainable Development Goals framework. Prof. Li officially launched two WDTA certification programs for AI professionals: the “Certified Large Language Model Application Engineer (LLMAE)” and the “Certified Large Language Model Technical Expert (LLMTE)”. These programs are designed to accelerate the training of the next generation of AI professionals, equipping them with both technical expertise and a sense of social responsibility to promote the safety, trust, and responsible development of AI. Prof. Li emphasized, “These certification programs represent a significant step by WDTA to advance global AI talent development. We must establish technical standards and cultivate professionals who embody the principles of ‘human-oriented and safety-based’ to ensure that technological advancements truly benefit society.” Prof. Ching-chuen Chan, Founder of IASTIC, stated, “As a global innovation hub, Hong Kong is an ideal platform to advance AI governance and collaboration. The WDTA will adhere to the core principles of ‘Speed, Safety, and Sharing’, and leverage The Institute to accelerate collaboration among governments, industries, and academia in the APAC. This will facilitate the formulation of digital technology standards and the transformation of cutting-edge research into practical applications. We will lead the establishment of AI STR standards and certification systems, enhancing the international framework for AI governance and security. By working together across industries and borders, we can achieve an inclusive digital future where no one is left behind.” At the forum, Cyberport signed a Memorandum of Understanding (MoU) with WDTA and IASTIC, under which the three parties will join hands to promote best practices in AI STR testing and evaluation. They will work together to actively cultivate AI talent and explore collaboration in the development of AI testing infrastructure. Cyberport also signed MoUs with five local tertiary institutions: the University of Hong Kong (HKU), the City University of Hong Kong (CityUHK), the Hong Kong Metropolitan University (HKMU), the Technological and Higher Education Institute of Hong Kong (THEi), and the Hong Kong Institute of Information Technology (HKIIT). These partnerships aim to foster AI-related applied research and talent development. These partnerships will provide students at the partner institutions with internships and employment opportunities, injecting new forces into Hong Kong’s AI industry and accelerating its growth. In addition to leading AI academics and experts, the forum also brought together leaders from Hong Kong’s public, financial, and healthcare sectors to share their valuable insights and practical experiences on topics such as cross-industry AI transformation and balancing AI

Scroll to Top

Subscribe
FREE Newsletter